Icon PLC (ICLR)

76.55
0.32 0.42
NASDAQ : Health Care
Prev Close 76.23
Open 75.96
Day Low/High 75.66 / 77.00
52 Wk Low/High 62.31 / 82.47
Volume 71.49K
Avg Volume 477.60K
Exchange NASDAQ
Shares Outstanding 55.46M
Market Cap 4.18B
EPS 4.10
P/E Ratio 18.96
Div & Yield N.A. (N.A)

Latest News

ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting

ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting

ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that all resolutions at the Annual General...

ICON To Acquire Clinical Research Management, Inc.

ICON To Acquire Clinical Research Management, Inc.

ICON plc , (NASDAQ:ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has agreed, subject to certain...

Healthcare Opportunities in Light of Brexit-Driven Selloff

Healthcare Opportunities in Light of Brexit-Driven Selloff

The sharp declines seen across the healthcare sector could present buying opportunities in companies such as Aetna, HCA, Icon and Paraxel.

ICON: DIA Live To Provide A Digital Window Into DIA Conference 2016

ICON: DIA Live To Provide A Digital Window Into DIA Conference 2016

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it will be presenting DIA Live - a social media...

New Research From ICON Demonstrates Support For 'Bring Your Own Device' Approach In Clinical Trials

New Research From ICON Demonstrates Support For 'Bring Your Own Device' Approach In Clinical Trials

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced research showing many pharmaceutical and clinical...

ICON Announces Service Agreement With Pfizer

ICON Announces Service Agreement With Pfizer

ICON plc, (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced it has signed a three-year agreement with Pfizer Inc.

ICON And Pfizer Honoured As Clinical Research Team Of The Year At The Clinical And Research Excellence Awards

ICON And Pfizer Honoured As Clinical Research Team Of The Year At The Clinical And Research Excellence Awards

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that, together with Pfizer, it has won the Clinical...

ICON Reports First Quarter 2016 Results

ICON Reports First Quarter 2016 Results

ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter...

Goldman Sachs Gives These 4 Cheap Stocks a Thumbs Up and So Do the Charts

Goldman Sachs Gives These 4 Cheap Stocks a Thumbs Up and So Do the Charts

Investors are on the hunt for cheap stocks. Here are four that are backed up by positive charts.

14 Cheap Stocks to Buy Now From Goldman Sachs

14 Cheap Stocks to Buy Now From Goldman Sachs

These 14 inexpensive stocks are expected to have strong top-line growth in the next two years, says Goldman Sachs.

Mr. Thomas Lynch Notifies ICON Of His Retirement As Chairman And That He Will Not Stand For Re-Election To The Board Of Directors At The Annual General Meeting

Mr. Thomas Lynch Notifies ICON Of His Retirement As Chairman And That He Will Not Stand For Re-Election To The Board Of Directors At The Annual General Meeting

ICON plc , (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that Mr.

ICON Selected By The International Consortium For Health Outcomes Measurement To Help Advance Value-based Healthcare

ICON Selected By The International Consortium For Health Outcomes Measurement To Help Advance Value-based Healthcare

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by the International...

ICON Reports Fourth Quarter And Full Year 2015 Results And Issues 2016 Earnings Guidance

ICON Reports Fourth Quarter And Full Year 2015 Results And Issues 2016 Earnings Guidance

ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the fourth quarter...

ICON Selected By Genomics England To Support The Largest Genome Sequencing Project Of Its Kind For Cancer And Rare Diseases (Graphic: Business Wire)

ICON Selected By Genomics England To Support The Largest Genome Sequencing Project Of Its Kind For Cancer And Rare Diseases (Graphic: Business Wire)

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Genomics England as...

ICON Secures Investment Grade Credit Ratings

ICON Secures Investment Grade Credit Ratings

ICON plc , (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported that Moody's Investors Service has assigned...

ICON Plc Announces Private Placement Of US$350,000,000 Of Senior Notes

ICON Plc Announces Private Placement Of US$350,000,000 Of Senior Notes

ICON plc , (NASDAQ: ICLR), today announced the successful completion and settlement of the private placement by its subsidiary ICON Investment Five Unlimited Company (the "Issuer") of $350,000,000 aggregate principal...

ICON Acquires PMG Research, Inc.

ICON Acquires PMG Research, Inc.

ICON plc , (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of PMG Research, Inc.

ICON Announces The Appointment Of Dr. Steve Cutler To Board Of Directors

ICON Announces The Appointment Of Dr. Steve Cutler To Board Of Directors

ICON plc , (NASDAQ:ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Dr.

10 High-Growth Health Care Stocks to Buy Now

10 High-Growth Health Care Stocks to Buy Now

Which health care stocks are both alluring - when it comes to rapid advances in new technology or a cure for a disease - but also sound investments?

ICON Reports Third Quarter 2015

ICON Reports Third Quarter 2015

ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the third quarter...

'Mad Money' Lightning Round: I'm Not Abandoning Rite Aid

'Mad Money' Lightning Round: I'm Not Abandoning Rite Aid

Cramer says Osiris Therapeutics is exciting, Opko Health is a buy and you can't go wrong with PPG Industries.

Jim Cramer's 'Mad Money' Recap: Be Patient, Then Start Buying

Jim Cramer's 'Mad Money' Recap: Be Patient, Then Start Buying

Markets weren't as overheated today, Cramer says. You can buy stocks at great prices if you are patient.

6 Mid-Cap Health Care Stocks to Buy

6 Mid-Cap Health Care Stocks to Buy

Here are six mid-cap health insurance companies to buy.

ICON And IBM To Revolutionise Clinical Trial Feasibility, Patient Recruitment And Study Start-up Timelines

ICON And IBM To Revolutionise Clinical Trial Feasibility, Patient Recruitment And Study Start-up Timelines

ICON plc, (NASDAQ:ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it is working with IBM (NYSE:IBM) to help reduce...

3 Stocks Pulling The Health Care Sector Downward

3 Stocks Pulling The Health Care Sector Downward

TheStreet highlights 3 stocks pushing the health care sector lower today.

Icon (ICLR) Marked As A Barbarian At The Gate

Icon (ICLR) Marked As A Barbarian At The Gate

Trade-Ideas LLC identified Icon (ICLR) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

ICON Reports Second Quarter 2015

ICON Reports Second Quarter 2015

ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second quarter...

ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting

ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting

ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that all resolutions at the Annual General...